Public Health Systems and Emerging Infections Assessing the Capabilities of the Public and Private Sectors: Workshop Summary (2000) / Chapter Skim
Currently Skimming:
Appendix D Forum Member and Staff Biographies
Appendix D Forum Member and Staff Biographies
Pages 97-110
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 97... ...
Subsequently, he moved to the Robert Wood Johnson Pharmaceutical Research Institute, where he served first as Head of Infectious Diseases and later as Executive 97
|
From page 98... ...
, Pediatric Infectious Diseases Society, and American Academy of Pharmaceutical Physicians (Vice President, Membership Development Committee, and board member)
|
From page 99... ...
He is founder of the Partnership for Prevention, a coalition of private-sector business and industry organizations, voluntary health organizations, and state and federal public health agencies based in Washington, D.C., that have joined together to work toward the elevation of disease prevention among the nation's health policy priorities.
|
From page 100... ...
Depar~nent of State's Emerging Infectious Diseases Program and is responsible for heading the department's policy coordination on infectious diseases and human immunodeficiency virus-AIDS issues and integrating international health issues with economic and national security implications into U.S. foreign policy.
|
From page 101... ...
She is a frequent presenter at the Interscience Conference on Antimicrobial Agents and Chemotherapy and other major infectious disease congresses, and has been published in leading infectious disease periodicals such as the Journal of Virology, the Journal of Infectious Diseases, and Antimicrobial Agents and Chemotherapy.
|
From page 102... ...
In 1986, she came to NIAID as the influenza and viral respiratory diseases program officer in DMID and, in 1988, she was appointed chief of the respiratory diseases branch where she coordinated the development of acellular pertussis vaccines. She joined the Division of AIDS as deputy director in 1997 and was responsible for developing the Innovation Grant Program for Approaches in human immunodeficiency virus vaccine research.
|
From page 103... ...
Davison Professor and Chairman emeritus of pediatrics at Duke University Medical Center. He has concentrated his research on infectious diseases, focusing primarily on vaccine research and development, having developed the attenuated measles virus vaccine with Nobel Laureate John F
|
From page 104... ...
This Bureau is responsible for the surveillance and control of 51 infectious diseases and conditions reportable under the New York City Health Code. Current areas of concern include antibiotic resistance; foodborne, waterborne, and tickborne diseases; hepatitis C and biological disaster planning for the potential threats of bioterrorism and pandemic influenza.
|
From page 105... ...
He was principal organizer and Chair of the 1989 Conference on Emerging Viruses at the National Institutes of Health, and is a member of the Institute of Medicine Committee on Emerging Infections (1990-1992) , a current member of the Institute of Medicine Committee on Xenograft Transplantation, and Chair of the Microbiology Section of the New York Academy of Sciences.
|
From page 106... ...
Department of Agriculture. He recently served as a member of the Committee on the Department of Defense Persian Gulf War Syndrome Comprehensive Clinical Evaluation Program of the Institute of Medicine.
|
From page 107... ...
Before joining Wyeth-Ayerst, Dr. Shlaes was Professor of Medicine at the Case Western Reserve University School of Medicine and Chief of the Infectious Diseases Section and the Clinical Microbiology Unit at the Veterans Affairs Medical Center in Cleveland, Ohio.
|
From page 108... ...
Dr. Webb is Senior Medical Director in Infectious Diseases Global Marketing at Bristol-Myers Squibb, working on the strategy and development for the antiinfective portfolio including human immunodeficiency virus products.
|
From page 109... ...
Davis was an Assistant Professor of Medicine and Head of the Malaria Laboratory at the University of Maryland School of Medicine where he was the principle and coprinciple investigator on grants investigating the fundamental biology of malaria transmission, and on the development and testing of candidate malaria vaccines in human volunteers.
|
From page 110... ...
Her graduate work has included research and policy analysis on issues including environmental, biodiversity conservation, sustainable development, human health, and emerging and reemerging infectious diseases. In August 1998, she participated in an educational program in Kenya that studied the relationship between ecological degradation and emerging infectious diseases.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.